VVUS

VIVUS, Inc. News Headlines

$2.32
*  
0.04
1.69%
Get VVUS Alerts
*Delayed - data as of Jul. 1, 2015  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VVUS Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Arena's Belviq Scripts Showing Traction - Vivus As Well
1/17/2014 1:52:00 PM - Seeking Alpha


Vivus Gains Insurance Traction With Qsymia
1/14/2014 1:44:00 PM - Seeking Alpha




Orexigen Receives Good News From FDA
1/7/2014 2:36:00 PM - Seeking Alpha


Arena's Belviq Closes Out 2013; Begins 2014
1/7/2014 12:39:00 AM - Seeking Alpha


Vivus Scores Insurance Win
1/2/2014 12:09:00 PM - Seeking Alpha


SA PRO: Top Long And Short Ideas, Tuesday December 31
1/1/2014 7:30:00 AM - Seeking Alpha




Arena Pharmaceuticals - A 2014 Story
12/26/2013 4:14:00 PM - Seeking Alpha


The Obesity Drug Industry Going Into 2014
12/26/2013 6:24:00 AM - Seeking Alpha


Vivus Inks Deal On Erectile Dysfunction Drug
12/13/2013 1:26:00 AM - Seeking Alpha


Orexigen Officially Files FDA Application For Contrave
12/13/2013 1:00:00 AM - Seeking Alpha


Is EnteroMedics Ready To Rise Again?
12/12/2013 1:56:00 PM - Seeking Alpha














Latent Disconnect Between Arena's Fundamentals And Valuation
10/29/2013 3:33:00 PM - Seeking Alpha




Vivus Outlines Key Data Points
10/16/2013 1:45:00 AM - Seeking Alpha